- completedPhase III
Treatment of autoimmune encephalitis in adults with intravenous immunoglobulin
Autoimmune encephalitis causes brain swelling when the immune system mistakenly attacks healthy brain tissue. This UK clinical trial investigates whether giving a treatment called intravenous immunoglobulin (IVIG) straight away helps adults recover faster and more fully, alongside standard steroid medicines. Half receive IVIG, and half receive a dummy drip.
United Kingdom · England · Scotland - active not recruitingPHASE2
IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2
This study looks at whether special treatments called immunotherapy can help people with a type of psychosis linked to the body's immune system. Researchers want to see if these treatments, intravenous immunoglobulin (IVIG) and rituximab, are safe and effective for this condition.
United Kingdom - recruiting
Characterization of Immune-response in Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes
This study looks into rare brain conditions called Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes. Researchers want to better understand how the body's immune system causes these conditions by studying blood and spinal fluid. This could lead to better ways to diagnose and treat these often severe, but sometimes curable, illnesses.
France